VISTIN PHARMA ASA [CBOE]
VISTIN PHARMA ASA [CBOE]
- NOK (-)
- Real time data - Cboe CH/DK/FI/NO/SE
Open: -
Change: -
Volume: -
Low: -
High: -
High / Low range: -
Type: Stocks
Ticker: VISTN_NO
ISIN: NO0010734122

Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungary)

  • 60

Oslo, Norway, 4 March 2024

Vistin Pharma has aquired a 15% share in CF Pharma Kft. CF Pharma is an API CDMO located in Budapest, Hungary with a broad customer base of recognized international pharmaceutical companies. CF Pharma has a proven track record in developing and commercializing Active Pharmaceutical Ingredients (APIs). The group/company currently has five commercial APIs on the market, with another eight APIs under development.

The transaction price consists of a base price and an earn-out- element, with an agreed cap of MEUR 1.6.

“We have had positive discussions with CF Pharma management and the majority shareholders for some time, to evaluate different partnership models. I am very pleased to announce that Vistin Pharma now has acquired a minority stake in CF Pharma. We see this as a first agreed step in a potential closer partnership in the future, which can broaden our product portfolio and form an important basis for future growth. The cooperation with CF Pharma is a first move in order for Vistin Pharma to execute on the strategy to become a multi-product European API Contract Development and Manufacturing Organization (API CDMO)”, says Magnus Tolleshaug, CEO in Vistin Pharma."


For further information, please contact:

Magnus Tolleshaug
CEO
+47 48 40 52 46
[email protected]

Alexander Karlsen
CFO
+47 97 05 36 21
[email protected]

 

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

ti?nf=MTAwMDkyNjg2MyM0MDE3NzY4MzEjMjAxODc1NA==
Vistin-Pharma-ASA.png

Primary Logo

GlobeNewsWire
GlobeNewsWire

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases, financial disclosures and multimedia content to media, investors, and consumers worldwide.